Abstract |
Relapsing experimental autoimmune encephalomyelitis (R-EAE) is a CD4+ T cell-mediated demyelinating disease model for multiple sclerosis. Myelin destruction during the initial relapsing phase of R-EAE in SJL mice initiated by immunization with the proteolipid protein (PLP) epitope PLP139-151 is associated with activation of T cells specific for the endogenous, non-cross-reactive PLP178-191 epitope (intramolecular epitope spreading), while relapses in R-EAE induced with the myelin basic protein (MBP) epitope MBP84-104 are associated with PLP139-151-specific responses (intermolecular epitope spreading). Here, we demonstrate that T cells specific for endogenous myelin epitopes play the major pathologic role in mediating clinical relapses. T cells specific for relapse-associated epitopes can serially transfer disease to naive recipients and are demonstrable in the CNS of mice with chronic R-EAE. More importantly, induction of myelin-specific tolerance to relapse-associated epitopes, by i.v. injection of ethylene carbodiimide-fixed peptide-pulsed APCs, either before disease initiation or during remission from acute disease effectively blocks the expression of the initial disease relapse. Further, blockade of B7-1-mediated costimulation with anti-B7-1 F(ab) during disease remission from acute PLP139-151-induced disease prevents clinical relapses by inhibiting activation of PLP178-191-specific T cells. The protective effects of anti-B7-1 F(ab) treatment are long-lasting and highly effective even when administered following the initial relapsing episode wherein spreading to a MBP epitope (MBP84-104) is inhibited. Collectively, these data indicate that epitope spreading is B7-1 dependent, plays a major pathologic role in disease progression, and follows a hierarchical order associated with the relative encephalitogenic dominance of the myelin epitopes (PLP139-151 > PLP178-191 > MBP84-104).
|
Authors | C L Vanderlugt, K L Neville, K M Nikcevich, T N Eagar, J A Bluestone, S D Miller |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 164
Issue 2
Pg. 670-8
(Jan 15 2000)
ISSN: 0022-1767 [Print] United States |
PMID | 10623809
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibodies, Monoclonal
- Autoantigens
- B7-1 Antigen
- Epitopes, T-Lymphocyte
- Immunodominant Epitopes
- Myelin Basic Protein
- Myelin Proteolipid Protein
- Peptide Fragments
- myelin basic protein 84-104
- myelin proteolipid protein (139-151)
|
Topics |
- Adoptive Transfer
- Amino Acid Sequence
- Animals
- Antibodies, Monoclonal
(administration & dosage)
- Autoantigens
(administration & dosage, biosynthesis, physiology)
- B7-1 Antigen
(immunology, physiology)
- Encephalomyelitis, Autoimmune, Experimental
(etiology, immunology, pathology, prevention & control)
- Epitopes, T-Lymphocyte
(administration & dosage, biosynthesis, physiology)
- Female
- Immune Tolerance
(immunology)
- Immunodominant Epitopes
(physiology)
- Lymphocyte Activation
(immunology)
- Mice
- Mice, Inbred Strains
- Molecular Sequence Data
- Myelin Basic Protein
(administration & dosage, immunology, physiology)
- Myelin Proteolipid Protein
(administration & dosage, immunology, physiology)
- Peptide Fragments
(administration & dosage, immunology, physiology)
- Recurrence
- T-Lymphocytes
(transplantation)
- Time Factors
|